Recent studies suggest that with or without diabetes, the administration of GLP-1 receptor agonists alone or in combination with metformin generally improves weight and glucose parameters in women with obesity and PCOS [49]. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.